SUMMARY HLA haplotype sharing was studied in 35 sibships in which there were two or more members with rheumatoid arthritis (RA). Haplotype sharing by RA siblings was random in 15 sibships which included members with clinical or immunological features of autoimmune thyroid disease. In the remaining 20 'non-thyroid' sibships the frequencies of RA siblings sharing 0, 1, or 2 haplotypes were 004, 0-48, and 0O48 respectively (p=0006). 67% of RA probands in the 'thyroid' families and 90% in the other families were HLA-DR4 positive. It is suggested that there is genetic heterogeneity in the pathogenesis of RA with at least two independent genes within the major histocompatibility complex (MHC) predisposing to RA. One gene is in linkage disequilibrium with HLA-DR4, while results of comparison of DR antigen frequencies in DR4 negative RA and control groups suggest that the other is in linkage disequilibrium with HLA-DR1 and 3. In the thyroid disease families both genes are frequently present and as either may predispose to arthritis, HLA haplotype sharing is random. The frequencies of HLA haplotype sharing in the 'non-thyroid' families suggest that there is a dominant susceptibility gene in linkage disequilibrium with HLA-DR4, whose frequency is 5% and penetrance about 20%.
Rheumatoid arthritis (RA) is thought to be caused by an interaction between a polygenic disease susceptibility and unknown environmental factors.'
There is a well documented association between RA and HLA-DR4 in most populations studied,2 suggesting that a gene or genes within the MHC may be responsible for at least part of this genetic susceptibility. The presence of DR4 If HLA haplotypes are inherited at random in a particular sibship the probabilities of any sib sharing 0, 1, or 2 haplotypes with a proband are 0-25, 0-5, and 0-25 respectively. The probabilities that the observed frequencies of haplotype sharing differ significantly from the random distribution were analysed by assessing the number of times parental haplotypes were repeated in affected siblings.6 p Values of less than 5% were considered statistically significant.
Results
Fifteen sibships contained individuals with clinical or immunological evidence of autoimmune thyroid disease. There were no overall clinical differences in rheumatoid disease severity between members of these 'thyroid' sibships and affected members of the other 'non-thyroid' sibships. (82% of RA subjects in the 'thyroid' and 84% in the 'non-thyroid' sibships had received 'second-line' drug therapy, and 71% of RA subjects in 'thyroid' and 65% in 'non-thyroid' sibships had irreversible articular deformities). 69% of RA members in the 'thyroid' families and 63% in the 'non-thyroid' families were seropositive for rheumatoid factor at the time of assessment. Ten of 15 (67%) probands in the thyroid families and 18 of 20 (90%) in the non-thyroid familiees were HLA-DR4 positive.
HLA haplotype sharing by RA sibs overall was significantly greater than random ( Table 1 ). The collagen. An association between RA and HLA-DR1 has been described in Israeli Jews8 and in Indian Asians studied in the UK9 but not in a subsequent study of RA in India.10 HLA-DR3 may act as a marker for high immune responder genes, as suggested by the association between this antigen and high autoantibody titres, immunological side effects of gold and penicillamine, and certain extraarticular disease features of RA." We have compared DR antigen frequencies found in a random group of unrelated, DR4 negative, Caucasoid, RA patients seen in Greater Manchester with antigen frequencies found in DR4 negative controls (Table 2) . Although there is a slight increase in both DR3 and DR1 in the RA group, neither difference is statistically significant. However, there is a 
